Browse > Article
http://dx.doi.org/10.5762/KAIS.2015.16.11.7978

Prevalence and Management of Dyslipidemia Among Korean Adults: KNHANES 2010-2012  

Jang, Sungok (Korea Association of Health Promotion)
Lee, Jongseok (School of Business Administration, Hallym University)
Publication Information
Journal of the Korea Academia-Industrial cooperation Society / v.16, no.11, 2015 , pp. 7978-7989 More about this Journal
Abstract
Dyslipidemia is a major risk factor for cardio-cerebrovascular disease. Although the prevalence among Korean adults is very high, its management is known to be poor. The aim of this study was to access the prevalence, awareness, treatment, and control rates of dyslipidemia according to treatment guideline rather than diagnostic criteria. The risk factors for cardio-cerebrovascular disease were evaluated to apply the appropriate risk-based threshold of the lipid treatment targets according to risk category. Analysis was done using nationally representative data (n = 16,263) collected from adults aged 20 years and older participating the Korea National Health and Nutrition Examination Survey (KNHANS) 2010-2012. The age-standardized prevalence rate of dyslipidemia according to treatment criteria was 34.1%. Of these prevalent cases, however, only 19.2% were aware; 9.5% treated; and 8.7% controlled. The age-standardized control rate among treated persons was 47.5%. Men had a significantly higher prevalence than women (39.7% vs. 28.8%), but a significantly lower rate of awareness, treatment, and control (16.0% vs. 22.3%, 7.7% vs. 11.3%, and 6.1% vs. 11.2%, respectively). As the higher risk category, the prevalence rate was higher but the control rate was lower. The prevalence of patients with diabetes was 82.5% when applying the treatment criteria (LDL-cholesterol level of ${\geq}100mg/dL$ and triglyceride level of ${\geq}200mg/dL$). However, only 11.9 % of these were controlled, whose LDL-cholesterol and triglycerides were lower than the treatment goals. Our findings suggest that effective strategies are required to decrease the gap between the prevalence of dyslipidemia and the following treatment. It would be worthwhile to strengthen the follow-up management of patients with dyslipidemia in the National Health Screening Program, especially in the high risk group of cardio-cerebrovascular disease.
Keywords
Dyslipidemia; Prevalence; Awareness; Treatment; Control; Follow-up Management;
Citations & Related Records
Times Cited By KSCI : 8  (Citation Analysis)
연도 인용수 순위
1 Statistics Korea, Annual report on the cause of death statistics, Daejeon: Statics Korea, 2015.
2 S. M. Grundy, "Small LDL, atherogenic dyslipidemia and the metabolic syndrome", Circulation, 95, pp. 1-4, 1997. DOI: http://dx.doi.org/10.1161/01.CIR.95.1.1   DOI
3 M. Haffnar, "Diabetes, hyperlipidemia and coronary artery disease", The American Journal of Cardiology, 83(9), pp. 17-21, 1999. DOI: http://dx.doi.org/10.1016/S0002-9149(99)00213-1   DOI
4 Korean Society of Lipidology and Atherosclerosis, Dyslipidemia Fact Sheet in Korea 2015, 2015.
5 E. Ahn, D. W. Shin, H. Yang, J. M. Yun, S. H. Chun, B. Suh et al., "Treatment Gap in the National Health-screening Program in Korea: Claim-based Follow-up of Statin Use for Sustained Hypercholesterolemia", Journal of Korean Medical Science, 30(9), pp. 1266-1272, 2015. DOI: http://dx.doi.org/10.3346/jkms.2015.30.9.1266   DOI
6 E. Roh, S. H. Ko, H. S. Kwon, N. H. Kim, J. H. Kim, C. S. Kim, et al., "Prevalence and Management of Dyslipidemia in Korea: Korea National Health and Nutrition Examination Survey during 1998 to 2010", Diabetes & Metabolism Journal, 37, pp. 433-449, 2013. DOI: http://dx.doi.org/10.4093/dmj.2013.37.6.433   DOI
7 T. Gordon. W. P. Castelli, M. C. Hjortland, W. B. Kannel, T. R. Dawber, "High density lipoprotein as a protective factor against coronary heart disease: The Framingham Study", The American Journal of Medicine, 62(5), pp. 707-714, 1977. DOI: http://dx.doi.org/10.1016/0002-9343(77)90874-9   DOI
8 Ministry of Health and Welfare (KR), 2014 revised criteria for medical care benefits: drug therapy for hyperlipidemia (Notice No. 2013-210), 2013.
9 Korea Centers for Disease Control and Prevention, The Fifth Korea National Health and Nutrition Survey (KNHANES V), 2010-2012. Available at: http://knhanes.cdc.go.kr/
10 S. M. Grundy, J. I. Cleemean, C. N. Merz, H. B. Brewer, L. T. Clark, D. B. Hunninghake, et al., "Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines", Circulation, 110(2), pp. 227-239, 2004. DOI: http://dx.doi.org/10.1161/01.CIR.0000133317.49796.0E   DOI
11 Committee for Guidelines for Management of Dyslipidemia, "2015 Korean Guidelines for Management of Dyslipidemia", Journal of Lipid and Atherosclerosis, 4(1), pp. 61-62, 2015. DOI: http://dx.doi.org/10.12997/jla.2015.4.1.61   DOI
12 World Health Organization, The Asia-Pacific perspective: redefining obesity and its treatment, Genova: World Health Organization Western Pacific Regional Office, 2000.
13 Korea Centers for Disease Control and Prevention, Korea Health Statistics 2012: National Korea National Health and Nutrition Survey (KNHANES V), 2013.
14 Y. G. Cho, H. J. Song, B. J. Park, NCEA-9 Lipid Agents Research Group, "The comparison of guidelines for management for dyslipidemia and the appropriateness of them in Korea", Korean Journal of Family Medicine, 31(3), pp. 171-181, 2010. DOI: http://dx.doi.org/10.4082/kjfm.2010.31.3.171   DOI
15 E. S. Kim, K. W. Kim, Y. C. Cho, "Prevalence of Clustering of Coronary Risk Factors in Health Checkup Examinees", Journal of the Korea Academia-Industrial Cooperation Society, 10(3), pp. 625-633, 2009. DOI: http://dx.doi.org/10.5762/KAIS.2009.10.3.625   DOI
16 J. C. LaRosa, S. M. Grundy, D. D. Waters, C. Shear, P. Barter, J. C. Fruchart, et al., "Intensive lipid lowering with atorvastatin in patients with stable coronary disease", The New England Journal of Medicine, 352, pp. 1425-1435, 2005. DOI: http://dx.doi.org/10.1056/NEJMoa050461   DOI
17 National Health Insurance Service, 2015 Guideline for the Korea National Health Screening Program, 2014.
18 J. Stamlar, D. Wentworth, J. D. Neaton, "Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT)", JAMA, 256(20), pp. 2823-2828, 1986. DOI: http://dx.doi.org/10.1001/jama.256.20.2823   DOI
19 R. C. Turner, H. Millns, H. A. W. Neil, I. M. Stratton, S. E. Manley, D. R. Matthews, et al,, "Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS: 23)", The British Medical Journal, 316, p. 823, 1998. DOI: http://dx.doi.org/10.1136/bmj.316.7134.823   DOI
20 S. K. Park, Y. C. Cho, "Relationship Among Serum Lipid levels, Obesity, and Blood Pressure in Health Examined Adult Women, Journal of the Korea Academia-Industrial Cooperation Society, 14(9), pp. 4342-4348, 2013. DOI: http://dx.doi.org/10.5762/KAIS.2013.14.9.4342   DOI
21 C. G. Kim, "The Relationship of BMI, Smoking, and Drinking with Biomedical Parameters in 20s and 30s Men", Journal of the Korea Academia-Industrial Cooperation Society, 12(10), pp. 4425-4433, 2011. DOI: http://dx.doi.org/10.5762/KAIS.2011.12.10.4425   DOI
22 S. O. Jang, J. S. Lee, "Friedewald-Estimated Versus Directly Measured LDL-Cholesterol: KNHANES 2009-2010", Journal of the Korea Academia-Industrial Cooperation Society, 16(8), pp. 5492-5500, 2015. DOI: http://dx.doi.org/10.5762/KAIS.2015.16.5.5492   DOI
23 Committee for Establishing Treatment and Instruction for Dyslipidemia, Korean Guidelines for Management of Dyslipidemia (2nd ed.), The Korean Society of Lipidoloy and Atherosclerosis, 2009.
24 H. K. Lee, Y. S. Park "Effects of a Health Promotion Program on College Students Who are on the Brink of Dyslipidemia, Based on Cox's Interaction Model", Journal of the Korea Academia-Industrial Cooperation Society, 15(5), pp. 3058-3068, 2014. DOI: http://dx.doi.org/10.5762/KAIS.2014.15.5.3058   DOI